Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

" Exploring the World of Drugs: Mechanisms, Effects, and Therapeutic Uses - Pharmacology", Study notes of Nursing

Pharmacology is the study of drugs and their effects on living organisms. It encompasses a wide range of topics, including drug discovery and development, mechanisms of drug action, pharmacokinetics (how drugs are absorbed, distributed, metabolized, and eliminated by the body), pharmacodynamics (how drugs interact with their targets in the body), and toxicology (the study of the harmful effects of drugs). In your pharmacology notes, you may cover various classes of drugs, such as antibiotics, antihypertensives, analgesics, and psychotropic drugs. Each class has its own unique mechanism of action, indications, contraindications, side effects, and potential drug interactions. You may also discuss the principles of drug administration, such as routes of administration (oral, parenteral, topical, inhalation), dosage forms (tablets, capsules, injections, ointments), and dosing regimens (frequency, duration, titration). Furthermore, your notes may cover the therapeutic uses and limitat

Typology: Study notes

2022/2023

Uploaded on 05/03/2023

salma-bonifacio
salma-bonifacio 🇵🇭

5

(1)

1 document

1 / 10

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
THE CARDIOVASCULAR SYSTEM
INATROPIC DRUGS- increase the force of mycardial contraction; treat
symptoms of heart failure and manage atrial arrythmias; increase
stroke volume and cardiac output, slow conduction and cause diuresis
by increasing bloodflow to the kidneys.
ANTI-ARRYTHMIC DRUGS- used to suppress or regulate atrial and
ventricular conductions, disturbances, resulting from myocardial
infraction or MI in other causes; mostly have pro-arrythmic properties
meaning, they can precipitate or aggrivate an arrythmia.
ANTI-HYPERTENSSIVE DRUGS- it lowers blood pressure by inhibiting the
central or peripheral nervous system, the renin angiotensis
mechanism or sodium and chloride reabsorption in the renal tubutles;
prescribed to treat hypertension.
ANTI-ANGINALS- this drugs reduces myocardial oxygen demand and
increase blood flow to schemic ares of th myocardium; they terminate
acute anginal attacks and prevent Angina from occuring;
ACUTE ANGINA- is managed by a short acting nitrate (nitro-glycerin) to
reduce unrelieved chest pain during acute MI
A NGINA PREVENTION- is managed with one or more drugs including:
nitrates, beta adrenergic blockers, and also calcium channel blockers;
Antilipemics
ANTILIPEMICS - are used to prevent and treat atherosclyrosis
(accumulation of fats in the blood vessels causing them to narrow) ;
because of the adverse effects of this drugs dietray modification,
weight loss, excercise and smoke cessation are considered firts line of
treatment; anti-lypimic therapy might be indicated if this measures
are ineffective.
ANATOPHYSIO:
Blood Pressure- pressure of blood in our systemic circulation it is
highest when blood is edjected during systolic pressure; and lowest
during diastolic pressure affected by various factors such as, activity,
age, hormones via kidneys etc.
Fluid transfer- cyclic flow of the fluid from the interstistial space to
the capilliaries and back into the extraterstistial space; it depend on
capilliary hydrostatic pressure, permiability, osmotic pressure , and
open lymphatic channels if distributed it may lead to edema or
excessive fluid in the interstistial space.
Cardiovascular system- maily delivers blood all throughout our
body and it helps with proper body PH, electrolyte composition and
also regulation of our body temperature.
ALL CARDIAC DRUGS except digoxin an inatropic drug can causes
descreased blood pressure and orthostatic hypotension.
ANTIHYPERTENSIVE DRUG CLASSES- Treat High Blood Pressure
(Hypertension; elevation or increase in systolic and or diastolic
pressure); ABCD
A- ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE
INHIBITORS)
Angiotensin II Receptor Blockers (ARBs)
B- BETA BLOCKERS
C- CALCIUM CHANNEL BLOCKERS
D- DIURETICS (DILATORS)
1. ANGIOTENSIN- CONVERTING ENZYME (ACE) INHIBITORS
M.O. A: Block conversion of angiotensin I to angiotensin II,
preventing peripheral vasoconstriction; it enterupts the RAAS; can be
used alone or in combination with other agents such as diuretics and
or beta adrenergic blockers; reduces blood pressure but does not
affect the heart meaning it can be administered even with increased
HR
Angiotensin II- potent vasoconstrictor that increases peripheral
resistance and promotes the excretion of aldosterone that promotes
sodium and water retention
Reduction Angiotensin II- causes dilation of artereols; peripheral
vascular resistance also reduces; reduces aldosterone secretion, it
promotes excretion of sodium and water as a result, the amout of
blood the heart needs to pump also reduces decreasing blood
pressure.
DRUG EXAMPLE: (~PRIL)
• Captopril- for patients who have risk of heart failure; may become
less effective when administered with NSAIDS; can cause Proteinuria
(presence of protein in the urine) and severe allergic reactions;
usually given up to 3 doses
• Lisonipril and Ramipril- are for patients who have had an MI to
improve the survival rate; to reduce morbidity and mortality in
patients with left ventricular dysfunction
•Benezapril
•Enalapril
• INDICATIONS:
Treat mild hypertension; heart failure after an MI; reduce the risk of
MI, stroke, and death from cardiovascular causes; patient with water
and sodium retention and those who have impaired renal functions in
patients with diabetes
• C and PC:
- in patients with asthma, sinus bradycardia, cardiogenic shock,
second-or third-degree heart block, or overt cardiac failure;
- Used cautiously in pregnant or breast-feeding patients; impaired
hepatic function; and renal impairment.
•ADVERSE REACTIONS: Nagging nonproductive cough, headache,
fatigue, angioedema, Gl reactions, hyperkalemia, and increased blood
urea nitrogen (BUN) and creatinine levels
NURSING RESPONSIBILITIES:
- Administer captopril on an empty stomach; 1 hour before meals for
maximum effectiveness.
- Monitor the patient taking captopril for proteinuria every 2 to 4
weeks for the first 3 months of therapy to detect decreased renal
function.
- avoid sudden position changes to minimize orthostatic hypotension
- Encourage nonpharmacologic treatments for hypertension
- mostly effective when taken sublingually, Instruct patient not to
chew nor swallow the drug. Allow the drug to be dissolved under the
tongue.
KEY POINTS:
A- avoided for pregnant women and breastfeeding; can cause Angio
Edema
C- avoided for patients who have Cough
E- elevate sodium-potassium levels; avoid potassium sparing diuretics
Special precautions: to patients with kidney problems and patients
with elecvated creatinine
2. ANGIOTENSIN II-RECEPTOR BLOCKING AGENTS (ARBS)
M.O.A - Block the binding of angiotensin II to the angiotensin II
receptor, preventing the vasoconstriction and aldosterone-secreting
effects of angiotensin, thus lowering the blood pressure; if ACE
inhibitor is contraindicated, we can used ARBS; does not inhibit ACE;
may be used with diuretics
DRUG EXAMPLE: (~SARTAN)
• Losartan and Ibesartan- indicated for patients with type 2 diabetes
because of thier inherent renal protective effect
• Valsartan- alternative for ace inhibitors; management of heart
failure
• Telmisartan- used cautiously in patients with biliary dysfunction
pf3
pf4
pf5
pf8
pf9
pfa

Partial preview of the text

Download " Exploring the World of Drugs: Mechanisms, Effects, and Therapeutic Uses - Pharmacology" and more Study notes Nursing in PDF only on Docsity!

THE CARDIOVASCULAR SYSTEM

I NATROPIC DRUGS- increase the force of mycardial contraction ; treat symptoms of heart failure and manage atrial arrythmias ; increase stroke volume and cardiac output, slow conduction and cause diuresis by increasing bloodflow to the kidneys. ANTI-ARRYTHMIC DRUGS- used to suppress or regulate atrial and ventricular conductions, disturbances, resulting from myocardial infraction or MI in other causes; mostly have pro-arrythmic properties meaning, they can precipitate or aggrivate an arrythmia. ANTI-HYPERTENSSIVE DRUGS- it lowers blood pressure by inhibiting the central or peripheral nervous system , the renin angiotensis mechanism or sodium and chloride reabsorption in the renal tubutles; prescribed to treat hypertension. ANTI-ANGINALS- this drugs reduces myocardial oxygen demand and increase blood flow to schemic ares of th myocardium; they terminate acute anginal attacks and prevent Angina from occuring; ACUTE ANGINA- is managed by a short acting nitrate (nitro-glycerin) to reduce unrelieved chest pain during acute MI A NGINA PREVENTION- is managed with one or more drugs including: nitrates, beta adrenergic blockers, and also calcium channel blockers; Antilipemics ANTILIPEMICS - are used to prevent and treat atherosclyrosis ( accumulation of fats in the blood vessels causing them to narrow) ; because of the adverse effects of this drugs dietray modification, weight loss, excercise and smoke cessation are considered firts line of treatment; anti-lypimic therapy might be indicated if this measures are ineffective. ANATOPHYSIO: Blood Pressure- pressure of blood in our systemic circulation it is highest when blood is edjected during systolic pressure ; and lowest during diastolic pressure affected by various factors such as, activity, age, hormones via kidneys etc. Fluid transfer - cyclic flow of the fluid from the interstistial space to the capilliaries and back into the extraterstistial space; it depend on capilliary hydrostatic pressure, permiability, osmotic pressure , and open lymphatic channels if distributed it may lead to edema or excessive fluid in the interstistial space. Cardiovascular system- maily delivers blood all throughout our body and it helps with proper body PH, electrolyte composition and also regulation of our body temperature. ALL CARDIAC DRUGS except digoxin an inatropic drug can causes descreased blood pressure and orthostatic hypotension. ANTIHYPERTENSIVE DRUG CLASSES- Treat High Blood Pressure ( Hypertension ; elevation or increase in systolic and or diastolic pressure); ABCD A- ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE INHIBITORS)

- Angiotensin II Receptor Blockers (ARBs) B- BETA BLOCKERS C- CALCIUM CHANNEL BLOCKERS

D- DIURETICS (DILATORS)

1. ANGIOTENSIN- CONVERTING ENZYME (ACE) INHIBITORS

M.O. A: Block conversion of angiotensin I to angiotensin II , preventing peripheral vasoconstriction; it enterupts the RAAS ; can be used alone or in combination with other agents such as diuretics and or beta adrenergic blockers; reduces blood pressure but does not affect the heart meaning it can be administered even with increased HR Angiotensin II- potent vasoconstrictor that increases peripheral resistance and promotes the excretion of aldosterone that promotes sodium and water retention Reduction Angiotensin II- causes dilation of artereols ; peripheral vascular resistance also reduces ; reduces aldosterone secretion , it promotes excretion of sodium and water as a result, the amout of blood the heart needs to pump also reduces decreasing blood pressure. DRUG EXAMPLE: (~PRIL)

- Captopril- for patients who have risk of heart failure ; may become less effective when administered with NSAIDS ; can cause Proteinuria (presence of protein in the urine) and severe allergic reactions ; usually given up to 3 doses - Lisonipril and Ramipril - are for patients who have had an MI to improve the survival rate; to reduce morbidity and mortality in patients with left ventricular dysfunction **•Benezapril •Enalapril

  • INDICATIONS:** Treat mild hypertension ; heart failure after an MI; reduce the risk of MI , stroke , and death from cardiovascular causes; patient with water and sodium retention and those who have impaired renal functions in patients with diabetes - C and PC:
  • in patients with asthma, sinus bradycardia, cardiogenic shock, second-or third-degree heart block, or overt cardiac failure ;
  • Used cautiously in pregnant or breast-feeding patients ; impaired hepatic function; and renal impairment. •ADVERSE REACTIONS: Nagging nonproductive cough, headache, fatigue, angioedema , Gl reactions, hyperkalemia, and increased blood urea nitrogen (BUN) and creatinine levels
  • NURSING RESPONSIBILITIES: - Administer captopril on an empty stomach ; 1 hour before meals for maximum effectiveness.
  • Monitor the patient taking captopril for proteinuria every 2 to 4 weeks for the first 3 months of therapy to detect decreased renal function.
  • avoid sudden position changes to minimize orthostatic hypotension
  • Encourage nonpharmacologic treatments for hypertension
  • mostly effective when taken sublingually, Instruct patient not to chew nor swallow the drug. Allow the drug to be dissolved under the tongue. KEY POINTS: A- avoided for pregnant women and breastfeeding; can cause Angio Edema C- avoided for patients who have Cough E- elevate sodium-potassium levels ; avoid potassium sparing diuretics Special precautions: to patients with kidney problems and patients with elecvated **_creatinine
  1. ANGIOTENSIN II-RECEPTOR BLOCKING AGENTS (ARBS)_** M.O.A - Block the binding of angiotensin II to the angiotensin II receptor, preventing the vasoconstriction and aldosterone-secreting effects of angiotensin, thus lowering the blood pressure; if ACE inhibitor is contraindicated, we can used ARBS; does not inhibit ACE; may be used with diuretics **DRUG EXAMPLE: (~SARTAN)
  • Losartan and Ibesartan-** indicated for patients with type 2 diabetes because of thier inherent renal protective effect - Valsartan- alternative for ace inhibitors; management of heart failure - Telmisartan- used cautiously in patients with biliary dysfunction

- HYDRALASIN, LABETELOL AND METHYLDOPA- is safe to use for pregnant woman C AND PC:

  • contraindicated in patients with hypersensitivity to any ARB and during the second and third trimester of pregnancy.
  • Used cautiously in patients with renal or hepatic dysfunction and those with hypovolemia
  • Concurrent use with potassium-sparing diuretics and potassium supplements should be avoided; may increase diuretic effects and hyperkalemia
  • Increase serum lithium levels and the risk of toxicity - Olmesartan- causes possible angioedema •ADVERSE REACTIONS: - depression, dizziness, symptoms of upper respiratory tract infection - NURSING RESPONSIBILITIES:
  • Alert the practitioner for ARB intake before surgery because of blocking the renin-angiotensin system
  • Monitor the patient's blood pressure carefully ; additive therapy may be required if drug doesn't achieve desired levels
  • Instruct the patient to maintain fluid intake
  • Teach the patient ways to minimize orthostatic hypotension -Stress the **_importance of continuing with nonpharmacologic therapies
  1. BETA-ADRENERGIC BLOCKERS_** - this are one of the main drugs used for treatment of hypertension including ocular hypertension (increase of eye pressure; normal range is 10-21 millimeters mercury) ; for long term prevention of Angina M.O.A - Compete with epinephrine for beta-adrenergic receptor sites -Inhibit response to beta-adrenergic stimulation, thereby decreasing cardiac output; it reduce the force or contractility of the heart lowering demand for oxygen **DRUG EXAMPLES: (~OLOL)
  • CARDIO SELECTIVE DRUGS-** focuses in decreasing the heart rate ; it does not affect the lungs - NON-CARDIO SELECTIVE DRUGS- it also causes bronchoconstriction; Contraindicated in patients with A- asthma , COPD ; B - having av beta blockers ; C - congestive heart failure; D - diabetes for hypoglycemia - BETAXOLOL, CARTIOLOL,TIMOLOL
  • beta blockers that can be use to treat of occular hypertension - C AND PC: - Contraindicated in patients, sinus bradycardia, cardiogenic shock, second-or third degree heart block, or overt cardiac failure ; Used cautiously in pregnant or breast-feeding patients and in those with impaired hepatic or renal function - ADVERSE REACTIONS: -bronchospasm, diarrhea, block, heart failure, and rash - NURSING RESPONSIBILITIES:
  • Warn not to stop taking the drug abruptly ; doing so can exacerbate angina or precipitate an MI - Administer propranolol consistently with meals
  • Withhold drug and notify the practitioner if the pulse rate is below 60 beats/minute
  • Don’t crush sustained-release tablets
  • Prevent or minimize orthostatic hypotension
  • IV forms may be given as a loading dose IV or may be **_diluted with normal saline solution and given by intermittent infusion.
  1. CALCIUM CHANNEL BLOCKERS_** -Treat mild hypertension, phem-arrythmias; Long-term prevention of angina that does not respond to any anti-aginal drugs; should not be used for short relieve of chest pain. - M.A.O: Dilate vessels by blocking the slow channel, preventing calcium from entering the cell or across the myocardial cell membrane and vascular smooth muscle cell s; reduces the workload of the heart ; also reduce the afterload resulting to decreased oxygen demand. FACTORS DETERMINING MYOCARDIAL OXYGEN DEMAND: Heart Rate; Heart Contractility; Ventricular wall tension. - DRUG EXAMPLES: Verapamil; Amlodipine Nicardipine; Diltiazem Nifedipine- focuses more on decreasing the blood pressure; may be given sublingually - C AND P.C: - patients with severe heart complications unless a functioning pacemaker is present; atrial flutter or fibrillation , heart failure , or severe hypotension
    • I.V. verapamil contraindicated in patients receiving I.V. beta- adrenergic blockers and those with ventricular tachycardia
    • Used cautiously in elderly patients and those with impaired hepatic or renal function or increased ICP - ADVERSE REACTIONS: AV heart blocks, edema, bradycardia, ventricular asystole, and ventricular fibrillation - NURSING RESPONSIBILITIES:
    • Withhold and notify if the patient's systolic pressure is less than 90 mm Hg or the heart rate is less than 60 beats/minute
    • Monitor the patient for signs and symptoms of heart failure
    • Warn the patient not to stop the drug abruptly; gradually reducing the dosage under practitioner's supervision helps prevent rebound hypertension
    • Administer diltiazem before meals 5. INOTROPIC DRUGS , CARDIAC GLYCOSIDES
    • increase the strength and the contractility of the hearts muscle tissue as its positive Inotropic effect; this could also slow the heart rate which is the negative effect; slowing the electrical impulse conduction through the AV node; improve and help decrease edema ; prevent remodeling of the left right ventricle in patients with heart failure - M.A.O:
    • Inhibit the sodium-potassium activation of adenosine triphosphate -Promote movement of calcium from extracellular to intracellular cytoplasm and cause positive inotropic effect
    • Act on the (CNS) to enhance vagal tone, slowing contractility through the SA and AV nodes as its negative chronotropic action - DRUG EXAMPLE: DIGOXIN- has long half-life ; must be given to a patient who requires immediate drug effect ; larger initial dose effective concentration may be reached faster ; loading dose should be avoided to prevent toxicity - INDICATIONS: Treat heart failure Control ventricular rate in atrial fibrillation, atrial flutter , and paroxysmal atrial tachycardia - C AND P.C: - Uncontrolled ventricular arrhythmias , idiopathic hypertrophic subaortic stenosis , constrictive pericarditis , complete heart block, and sick sinus syndrome ; Used cautiously in patients with acute MI because it increases the risk of arrythmias - ADVERSE REACTIONS:
    • complete heart block , and vision changes
    • Possible digoxin toxicity; VANDAO
    • Increased risk in patients with hypercalcemia, HYPOKALEMIA, hypomagnesemia, hypothyroidism, or renal failure
    • Increased risk in elderly patients because they're more sensitive; anorexia is a warning sign - NURSING RESPONSIBILITIES:
    • Assess the patient's apical pulse, serum drug and electrolyte levels, and renal function before administering digoxin
    • Withhold and notify if the pulse rate is less than 60 beats/minute or the minimum specified.
    • Don't alternate dosage forms because bioavailability of capsules doesn’t equal that of tablets or elixir.
    • DIGOXIN IMMUNE FAB used as an antidote in extreme toxicity
    • Be aware that hypokalemia risk toxicity
    • Warn patient not to take a double dose after missing a dose
    • Teach the patient how to recognize signs and symptoms of digoxin toxicity and heart failure. -Know that because digoxin is excreted unchanged by the kidneys the

•Assess for paradoxical bradycardia when administering atropine in low doses or by slow infusion •Administer adenosine by rapid I.V. bolus to prevent complications; drug has a very short half-life

  • Monitor the patient's heart rate, respiratory rate, and blood pressure for signs of complications •Monitor the ECG •Administer antiarrhythmics around the clock , as prescribed •Know that I.V. antiarrhythmics must be administered by infusion pump for accuracy •Teach the patient the purpose of the prescribed antiarrhythmic NORMAL HEART RATE: 60-100 bpm ; hemodynamically stable BRADYCARDIA: Less than 60 bpm ; TACHYCARDIA: More than 100 bpm ; HOW TO READ ECG/EKG:

DRUGS AFFECTING THE HEMATOLOGIC SYSTEM

1. HEMATOPOIETICS

MAO: Supplement and replace depleted iron stores in bone marrow to assist in erythropoiesis (RBC production) DRUG EXAMPLES: Ferrous sulfate ; Ferrous gluconate Iron dextran ; Iron sucrose INDICATIONS

  • Prevent and treat iron deficiency and iron deficiency anemla
  • Dietary supplement for iron C AND P.C:
  • Patients with hemochromatosis , hemosiderosis, hemolytic anemias, peptic ulcer disease, inflammatory bowel disorders, or hypersensitivity to drug, tartrazine, or sulfites
  • Not intended for long-term use in patients with normal iron stores ADVERSE REACTIONS
  • Oral iron preparations: Nausea, vomiting, constipation, dark stools, diarrhea, and GI distress
  • Parenteral iron preparations: staining at the IM injection site, localized phlebitis at the I.V. injection site, and anaphylaxis
  • Liquid iron preparations: May temporarily stain teeth
  • Iron sucrose injection: Heart failure , sepsis , and mild to moderate hypersensitivity reactions (wheezing, dyspnea, hypotension, rash, pruritus) NURSING RESPONSIBILITIES -For oral administration: Give drug between meals; Give tablets with juice or water, not with milk or antacids ; orange juice or ascorbic acid promotes iron absorption ; Dilute liquid iron preparations, and give with straw to avoid staining teeth -For I.M. administration: Use Z-track technique to prevent leakage and staining into subcutaneous tissues
  • Use I.V. route in these situations:
  • Insufficient muscle mass for deep I.M. injection; Impaired absorption from muscle caused by stasis or edema -Possibility of uncontrolled I.M. bleeding from trauma occurs in hemophilia; Massive, prolonged parenteral therapy (may be necessary with chronic substantial blood loss; rule out hypersensitivity before administering drug I.V.
    • Flush vein with 10 ml of 0.9% sodium chloride solution on completion of I.V. iron dextran infusion
    • Instruct the patient to continue the regular dosing schedule after missing a dose; caution against doubling doses be aware of iron poisoning in children
    • Poisoning can occur within minutes to hours after swallowing tablets
    • Instruct the patient to drink at least 2 qt (2L) of fluid daily to increase fiber intake, and to exercise regularly to prevent constipation
    • Advise the patient to avoid antacids , coffee, tea, dairy products, eggs and whole grain breads for 1 hour before and 2 hours after taking oral iron preparations ; may interfere with absorption
    • Inform the patient that iron preparations may turn stools dark green black 2.BIOLOGIC RESPONSE MODIFIERS MAO: Stimulate RBC production in bone marrow by boosting erythropoietin production DRUG EXAMPLE: Epoetin alfa; Darbepoetin alfa INDICATIONS:
    • Treat anemia associated with chronic renal failure , whether or not the patient is on dialysis (darbepoetin alfa)
    • Treat anemia associated with end-stage renal disease, chemotherapy, or zidovudine therapy; Decrease need for perioperative blood transfusions in surgery patients (epoetin alfa) C AND PC: •Patients with uncontrolled hypertension or hypersensitivity to drug or drug components such as human albumin.
    • Epoetin alfa not intended for patients with chronic renal disease and severe anemia or for patients infected with human immunodeficiency virus or cancer patients with anemia that's caused by other factors, such as iron or folate deficiencies, hemolysis, or GI bleeding that should be managed •Used with extreme caution in pregnant and breast-feeding patients •Darbepoetin alfa used with extreme caution in patients with underlying hematologic disease (such as hemolytic anemia, sickle cell anemia, thalassemia, or porphyria); safety not established ADVERSE REACTIONS:
    • Hypertension , seizures, iron deficiency, increased risk of thrombotic events (including MI, stroke, or transient ischemic attack), hypersensitivity , and allergic reactions
    • Vascular access thrombosis , heart failure, sepsis, cardiac arrhythmias , infection, hypertension, hypotension, myalgia, headache, vomiting, chest pain, and diarrhea (darbepoetin alfa) NURSING RESPONSIBILITIES:
    • Monitor hemoglobin levels and hematocrit frequentl y; Rapid rise in hematocrit associated with seizures and hypertension
    • Adequate iron, folic acid, and vitamin B12 stores required for erythropoiesis
    • Institute seizure precautions , and closely monitor neurologic status •Monitor blood pressure for signs of hypertension frequently •Teachient or family the proper technique for subQ injection. 3.COLONY-STIMULATING FACTOR M.O.A: Stimulates production of granulocytes and macrophages in bone marrow by binding to specific cell surface receptors or stimulating leukopoiesis DRUG EXAMPLES •Filgastim •Pegfilgrastim •Aldesleukin INDICATIONS:
    • Treat aplastic anemia secondary to chemotherapy
    • Accelerate bone marrow recovery in malignant lymphoma and Hodgkin's disease •Treat delayed or failed bone marrow transplant
    • Increase WBCs in patients taking zidovudine C AND P.C•Filgrastim and pegfilgrastim are contraindicated in patients with hypersensitivity to Escherichia coli-derived proteins or other drug components

- Sargramostim contraindicated in patients with excessive leukemic myeloid blasts in bone marrow or peripheral blood (10% or more) or hypersensitivity to drug or its components; in patients receiving simultaneous administration of cytotoxic chemotherapy or radiotherapy ; and within 24 hours before or after chemotherapy or radiotherapy • Aldesleukin contraindicated in patients with serious cardiovascular disease ADVERSE REACTIONS: Respiratory symptoms, supraventricular arrhythmias, bone pain, arthralgia, myalgia, anorexia, nausea, vomiting, diarrhea, stomatitis, fluid retention, and hypersensitivity reactions NURSING RESPONSIBILITIES •Monitor WBC count •Monitor for signs and symptoms of infection

  • Discontinue drug when absolute neutrophil count is 10000 for filgrastim and 20,000 for sargramostim •Know that pegfilgrastimis longer acting than filgrastrim
  • Don't administer filgrastim within 24 hours of antineoplastic drugs •Instruct the patient or family in proper technique for subQ injection •Teach the patient the importance of maintaining nutritionally balanced diet and complying with therapeutic regimen 4.ANTICOAGULANTS HEPARIN AND HEPARIN DERIVATIVES M O A: Prevent extension and formation of clots by inhibiting factors in clotting cascade **DRUG EXAMPLES
  • I.V. forms:** bivalirudin (Angiomax), heparin, lepirudin (Refludan), tinzaparin (Innohep) - SubQforms: dalteparin (Fragmin), enoxaparin(Lovenox) - Oral forms: warfarin (Coumadin, Jantoven) INDICATIONS: •Treat or prevent thromboembolic disorders (such as DVT, pulmonary embolus, and atrial fibrillation with embolization) and ischemic complications •Adjunct to aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (bivalirudin) •Treat or prevent heparin-induced thrombocytopenia (lepirudin) C AND PC: in patients with underlying coagulation disorders, ulcer disease, recent surgery, cancer, or active bleeding patients with severe thrombocytopenia or uncontrolled bleeding ; and those with hypersensitivity to drug or drug components
  • Enoxaparin sodium not recommended for patients with prosthetic heart valves; higher risk for thromboembolism ADVERSE REACTIONS: •Fever, pain at injection site, nausea, constipation, and insomnia
  • Hyperlipidemia, thrombocytopenia (with heparin) , hemorrhages, and spinal or epidural hematoma (with indwelling catheters) NURSING RESPONSIBILITIES
  • Don't give heparin by I.M. routeMinimize venipunctures and injections •Know that heparin is given initially because of its rapid action -The patient may then be started on warfarin which takes several days to reach therapeutic levels •Once therapeutic levels are reached , heparin will be discontinued and the patient maintained on warfarin •Be aware that heparin directly affects partial thromboplastin time (PTT) and warfarin directly affects prothrombin time (PT) and international normalized ratio (INR) •Monitor PTT in the patient taking argatroban •Know that enoxaparin usually doesn't significantly affect INR, PT, PTT , or platelet function
  • Inject subQ heparin and enoxaparin into abdomen -Don't aspirate or rub injection site •Know that PROTAMINE SULFATE is an antidote for heparin and that PHYTONADIONE (VITAMIN K) is an antidote for warfarin
  • Monitor hemoglobin and clotting factor and platelet levels
  • Instruct the patient to use a soft toothbrush and an electric razor to prevent trauma and bleeding
  • Instruct the patient to inform the practitioner and dentist of the medication regimen before undergoing any medical treatments
  • Caution the patient not to increase dietary vitamin K or drastically and suddenly change diet ; doing either of these can impair warfarin's effectiveness •Teach the patient the importance of routine laboratory tests to monitor coagulation times •Instruct the patient not to take any drugs or vitamins, including overthe-counter or herbal preparations , unless directed by the practitioner 5.ANTIPLATELET DRUGS MOA: Interfere with platelet aggregation in different drug-specific and dosespecific ways, preventing thromboembolic events DRUG EXAMPLES: - ASPIRIN- Prophylaxis for thromboembolic event s and intermittent claudication Reduce risk of death in patients with previous MI or unstable angina and risk of transient ischemic attacks in men - CLOPIDOGREL- Reduce risk of cardiovascular event and death in patients with recent MI or stroke , established peripheral arterial disease , or acute coronary syndrome - CILOSTAZOL- Reduce symptoms of intermittent claudication - TICLOPIDINE- Second-line drug in prevention of stroke in high-risk individuals C AND PC: Contraindicated in patients with active bleeding , thrombocytopenia, history of hemorrhagic stroke , severe liver impairment, underlying coagulation disorders , ulcer disease, recent surgery, or cancer ADVERSE REACTIONS: •Dizziness, diarrhea, abnormal stools, headache, infection, rash, nausea and pain at injection site ; Possible bleeding, pancytopenia, neutropenia or agranulocytosis (ticlopidine), hemorrhage, or thrombotic thrombocytopenic purpura NURSING RESPONSIBILITIES: - Monitor for bruising and evidence of bleeding - Monitor hemoglobin and clotting factor and platelet levels •Minimize v enipunctures and injections; apply pressure to all puncture sites to prevent bleeding - Stop drug 5 to 7 days before surgery, or as ordered by the practitioner - Withhold dose and notify the practitioner if the patient develops bleeding s alicylism, or adverse GI reactions •Monitor for bruising and evidence of bleeding 6.FACTOR Xa INHIBITORS MECHANISM OF ACTION: Block factor Xa , altering the clot formation process DRUG EXAMPLES: Fondaparinux (Arixtra) INDICATIONS: Prevention of DVT in patients undergoing abdominal surgery or surgery for hip fracture, hip replacement, or knee replacement Adjunct to warfarin for treatment of acute DVT and pulmonary embolism C AND P.C: - Contradicted in patients with active bleeding, thrombocytopenia, severe renal impairment, or bacterial endocarditis and in those weighing less than 110 lb(50 kg) ; Used cautiously in patients with bleeding disorders , renal impairment, uncontrolled hypertension, GI ulcer, or diabetic retinopathy and in those who had a recent spinal puncture ADVERSE REACTIONS: Fever, spinal and epidural hematoma, nausea, hemorrhage, thrombocytopenia, injection site irritation, rash, and anemia NURSING RESPONSIBILITIES: •Monitor for signs and symptoms of bleeding •Monitor the patient who had epidural or spinal anesthesia for formations of spinal or epidural hematoma - Monitor laboratory results , including CBC, platelet count, and renal function tests •Know that PT and PTT tests are ineffective in monitoring drug levels - Be aware that factor Xa inhibitors aren't interchangeable with heparin derivatives 7. THROMBOLYTICS MECHANISM OF ACTION: Activate plasminogen, leading to its conversion to plasmin ( clot-degrading substance ) DRUG EXAMPLES: Reteplase ; Urokinase ; Streptokinase Alteplase ;

phenothiazines, and trimethobenzamide : Act on CNS to prevent nausea and vomiting Manage nausea and vomiting associated with chemotherapy Trimethobenzamidel - can cause hypotension, pain at I.M. injection site, and rectal irritation with suppositories. Phenothiazines- contraindicated in angle-closure glaucoma, bone marrow depression, and severe liver or heart disease; side effects inclide Hypotension, constipation, blurred vision, dryness of eyes and mouth, extrapyramidal reactions, and photosensitivity reactions

• Dimenhydrinate, meclizine, and scopolamine: Reduce motion

sickness by inhibiting impulses from inner ear to the vestibular pathway Dimenhydrinate is contraindicated in patients hypersensitive to drug or its components; I.V. form contains benzyl alcohol, which has been associated with fatal "gasping syndrome“ in neonates

- Metoclopramide: Increases the rate of gastric emptying and enhances gastroesophageal sphincter tone; Promote gastric emptying in patients receiving tube feedings and those with diabetic gastroparesis; contraindicated in suspected GI obstruction; used cautiously and at reduced dose in patients with renal impairment NURSING RESPONSIBILITIES: •Decrease initial dose of metoclopramide by 50% of usual recommended dose if creatinine clearance is less than 40 ml/minute •Instruct the patient tking phenothiazines to minimize orthostatic hypotension and to prevent photosensitivity reactions •Assess for nausea and vomiting and fluid and electrolyte imbalances •Caution the patient to avoid activities requiring alertness until drug response is known •Inform the patient that frequent mouth rinses, good oral hygiene, and sugarless gum or candy may reduce dry mouth •Advise the patient to take oral antiemetics 1 hour before exposure to conditions causing motion sickness 6. ANTIDIARRHEALS - Control and relieve symptoms of acute or chronic nonspecific diarrheaControl and relieve symptoms of acute or chronic nonspecific diarrhea •Camphorated opium tincture, difenoxin, diphenoxylate, and loperamide: Slow intestinal motility, ultimately reducing water absorption from stools; can cause constipation drowsiness •Bismuth, kaolin and pectin mixture, and polycarbophil: Reduce fluid content of stools •Octreotide : Decreases volume of gastric and intestinal secretions and diarrhea secondary to vasoactive intestinal tumors (such as carcinoid tumors) can cause nausea, abdominal pain, pain at injection site, and gallstones NURSING RESPONSIBILITIES: •Assess monitor fluid and electrolyte balance for dehydration resulting from diarrhea •Auscultate for bowel sounds; and evaluate stools for frequency and consistency •Know that high-dose, long-term use of difenoxinor diphenoxylate may cause dependence (atropine has been added to these preparations to discourage abuse) •Don't confuse camphorated opium tincture with deodorized tincture of opium, which is 25 times more potent •Instruct the patient to notify the practitioner if diarrhea persists or fever occurs 7****. LAXATIVES Treat or prevent constipation and prepare bowel for radiologic or endoscopic procedures; Contraindicated in patients with persistent or severe; can cause nausea, vomiting, and abdominal cramping; Possible permanent loss of colonic motility, laxative dependence, and electrolyte imbalances with long-term use or abuse of laxatives. •Bulk-forming laxatives: Increase water content of stools, forming a viscous solution that promotes peristalsis and improves elimination rate D.E: Methylcellulose, polycarbophil, psyllium- Manage chronic watery diarrhea; can cause sophageal obstruction or intestinal obstruction •Lubricant laxatives: Increase water retention in stools, prevent water absorption from stools, and lubricate and soften intestinal contents D.E: Mineral oil (Fleet Mineral Oil Enema)- can cause lipid pneumonia and nutritional deficiencies •Hyperosmotic laxatives: Increase water content of stools and soften stools; lactulose also inhibits diffusion of ammonia from the colon into the blood reducing serum ammonia levels in patients with liver dysfunction D.E: Lactulose- Adjunctive treatment in managing hepatic encephalopathy; can cause cramps, distention, flatulence, and belching •Saline cathartic laxatives: Draw water into bowel, increasing the bulk of intestinal contents and stimulating peristalsis D.E: Magnesium Citrate, sodium biphosphate; can cause dehydration and electrolyte imbalances •Stimulant laxatives: Stimulate peristalsis and inhibit water and eloc electrolyte reabsorption from intestine D.E: Bisacodyl (Dulcolax), castor oil •Stool softeners: Allow more fluid and fat to penetrate feces, producing softer fecal mass D.E: Docusate calcium, docusate potassium, docusate sodium NURSING RESPONSIBILITIES: •Assess frank or occult bleeding auscultate for bowel sounds; and evaluate stools •Monitor for fluid and electrolyte imbalances •Mix bulk-forming laxatives in a full glass of fluid; give an additional gladd after administering •Assess the patient's mental status, level of consciousness •Dilute sodium phosphates with water before; monitor for electrolyte disturbances. - laxatives are for short-term use only and encourage use of other methods to regulate bowel.

DRUGS AFFECTING THE ENDOCRINE SYSTEM

Endocrine system- consist of organs and glands that are located throughout the body; secreting substance and hormones Hormones- travel through the blood system and then targets tissues; help balance and maintain the physiological stability and functioning of our body

- With CNS the endocrine system intergrates and regulates the body's metabolic activities and maintains homeostasis. The drugs type that treat endocrine disorders includes: The natural hormones (insulin and glucagon); hormone like substances and drugs that stimulates or s uppress hormone secretion Growth Hormone- which replace hormones in states of defficiency. 1. ANTIDIURETIC HORMONES - Enhance reabsorption of water in kidneys and smooth-muscle contraction (vasoconstriction), thereby promoting an antidiuretic effect and regulating fluid balance

  • Promotes vasoconstriction and decreases hepatic blood flow **DRUG EXAMPLES (~PRESSIN)
  • Desmopressin** (DDAVP, Stimate) - Control bleeding in hemophilia A and mild to moderate von Willebrand’s type 1 with factor VIII levels greater than 5 %; contraindicated in patients with type II B or pseudo (platelet-type) von Willebrand's disease. - Vasopressin (Pitressin)- Prevent and treat postoperative abdominal distention and dispel interfering gas shadows. Contraindicated in patients with anaphylaxis or hypersensitivity; those with chronic nephritis with nitrogen retention; Extreme caution with vascular disease (specifically coronary artery disease ), epilepsy, Migraines, asthma, heart failure, or states in which a rapid increase in extracellular water may result in further compromise. INDICATIONS:
  • Treat diabetes insipidus ( there is no antidiuretic hormone; there is increase urine output because of the damge in the brain); Nocturnal enuresis (night time bedwetting)

7D of D.I:

  1. Diuresis
  2. Diluted urine - decreased urine specific gravity = <1.
  3. Dry inside = "High dry labs" = increased sodium and increased osmolarity (concentrated blood)
  4. Dehydration
  5. Drinks a lot - excessive thirst (early sign)
  6. Decreased BP
  7. DESMOPRESSIN/VASOPRESSIN - ANTI-DIURETIC DRUG ADVERSE REACTIONS: Water intoxication or delutional hyponatremia, nasal congestion or changes; facial flushing, hypertension, epistaxis, sore throat, injection site swelling, and swelling or burning NURSING RESPONSIBILITIES •Monitor fluid intake and output and urine osmolality frequently
  • Teach the patient how to use intranasal drug
  • Complications that may decrease effects of intranasal therapy should be reported •Teach the patient to self-administer and alternate injection sites
  • Ingest only enough fluid to satisfy thirst to decrease the risk of water intoxication and hyponatremia
  • water intoxication include drowsiness and listlessness and that headaches precede coma and seizures •Know that desmopressin has greater antidiuretic response than vasopressin ;
    • I.V. administration is about 10 times greater than that following intranasal administration. 2.THYROID HORMONES - corrects thyroid hormone defficiency or hypothyroidism and excess (hyperthyroidism); can be natural or synthetic, can contain T3 or T4 or even both; replace endogenous thyroid hormones in defficiency states; control metabolic rate of tissues; accelerate heat production and oxygen consumption; Produce T3 activity and replace hormonal deficits or suppress excessive hormone production (synthetic thyroid hormones); Serum T4 and T levels are low, and thyroid-stimulating hormone (TSH) is increased. DRUG EXAMPLES: Levothyroxine (T4)- stimulates metabolism of all body tissue by accelerating the rate of cellular oxidation INDICATIONS:
  • Thyroid hormone replacement in primary or secondary hypothyroidism •Treat or prevent goiters by suppressing secretion of TSH from pituitary gland •Adjunct to antithyroid drugs to treat thyrotoxicosis, prevent goitrogenesis hypothyroidism , and prevent thyrotoxicosis during pregnancy MYXEDEMA - danger for patients with hyperthyroidism C AND PC: in patients with acute myocardial infarction (M.l) or thyrotoxicosis accompanied by hpothyroidism ; •When hypothyroidism and hypoadrenalism (Addison's disease) coexist; •Used cautiously in patients with heart disease, hypertension, diabetes mellitus or insipidus, myxedema, or adrenal insufficiency;
  • Not intended for use as weight control ADVERSE REACTIONS:
  • Signs and symptoms of hyperthyroidism or aggravated existing hyperthyroidism ; •Signs of overdose; possible decreased bone density with long-term use in women ; • Possible partial hair loss in children in first few months of therapy, (usually temporary) NURSING RESPONSIBILITIES
  • Administer drug in morning
  • take drug ·1 hour before meals or 2 hours after meals to improve drug absorption
  • Give drugs at least 4 hours apart because •Monitor pulse rate, and evaluate results of thyroid functions studies •Caution the patient not to change medication brands; potency differs among brands
  • Notify the practitioner symptoms of hyperthyroidism or other unusual events occur. 3.ANTITHYROID DRUGS - Used to treat hyperthyroidism especially Grave's disease the hyperthyroidism cause by auto immunity; increase T3 and T4 production along with the compensatory decrease of TSH.; treat hypersecretion and decrease the size and vascularity of the thyroid gland before surgery; Palliative treatment in selected cases of thyroid carcinoma - Iodine: Circulates into thyroid gland as iodide, which when oxidized helps yield thyroid hormones; large doses of iodide can inhibit T3 and T4 synthesis - Propylthiouracil (PTU) and methimazole: Inhibit synthesis of thyroid hormones; partially inhibits conversion of T4 to T - Sodium iodide: Limits thyroid hormone secretion by destroying thyroid tissue are contraindicated with patients younger than age 30 and those with preexisting vomiting and diarrhea DRUG EXAMPLES: - Iodine (Lugol’s solution)- Adjunctive therapy to treat hyperthyroidism and reduce thyroid friability Before surgery and to treat thyrotoxic crisis or neonatal thyrotoxicosis; Thyroid blocking during radiation emergency; contraindicated in pregnant patients and those hypersensitive to iodides - Methimazole- can be used in the second and thirdster; in category D; can be blocks thryroid hormone formation for a longer time it is better suited to be administered once per day therapy may continue for 12- 24 month; contraindicated in pregnant and breast-feeding patients - Propylthiouracil (PTU)- prefered in first trimester of pregnancy; in category D; Treat hyperthyroidism when thyroidectomy is contraindicated or inadvisable •THYROID STORM: triggered by stress or infection; calcium glutanated can be given; increased of body temp and altered lavel of concoiusness; tetany : –Trousseau sign –Chvostecksign ADVERSE REACTIONS:
    • Hypothyroidism, diarrhea, hypersensitivity, and iodism
    • Nausea, vomiting, agranulocytosis, and rash (methimazole and PTU)
    • Bone marrow depression, acute leukemia, anemia, radiation sickness, chest pains, tachycardia, itching, neck tenderness or swelling, sore throat, cough, and temporary hair thinning NURSING RESPONSIBILITIES: •Give drug at regular intervals ; usually every 8 hours at a consistent time; 1 hour before or hours after meals because food may affect drug absorption.
    • Dilute strong iodine solution to improve taste •Monitor serum thyroid levels and thyroid function test results •Assess for signs and symptoms of overdose, hypothyroidism or underdose, thyrotoxicosis
    • consult the practitioner before eating iodized salt and iodine rich foods •avoid aspirin and drugs containing iodine. 4. PARATHYROID AND ANTIHYPERCALCEMIC DRUGS - regulate calcium imbalances which usually result for underlying disorders - Parathyroid drugs: Increase serum calcium level, causing a corresponding decrease in the serum phosphate level Contraindicated in patients with hypersensitivity to bisphosphonates ; hypocalcemia, abnormalities of the esophagus that delay gastric emptying; inability to stand or sit upright for atleast 30 minutes, clinically overt osteomalacia, or severe renal impairment; taken cautiously in patients with renal failure. - Antihypercalcemicdrugs: Reduce serum calcium level by reducing bone resorption, increasing GI absorption of calcium, and interfering with renal calcium clearance; used cautiously in pregnant or breast- feeding patient (except zoledronic which is contraindicated) and those with asthma or upper GI problems. PARATHYROID DRUGS: Calcitriol, calcium carbonate, calcium citrate, calcium chloride, calcium gluconate, calcium lactate ANTIHYPERCALCEMIC DRUGS: Calcitonin, alendronate INDICATIONS:
    • Treat hypocalcemia, hypoparathyroidism, and pseudohypoparathyroidism
    • Prevent and treat osteoporosis
    • Treat hypercalcemia, Paget's disease, osteoporosis, heterotopic ossification, hypercalcemia of malignancy, metastasis of breast cancer, and osteolytic lesions of multiple myeloma (antihypercalcemicdrugs)

cirrhosis or heart failure; used cautiously in patients with liver impairment or edema NURSING RESPONSIBILITIES:

  • Take alpha-glucoside inhibitors with first bite of food and to take meglitinides within 30 minutes of each meal
    • In taking a sulfonylurea to use sunscreen and protective clothing to prevent photosensitivity reactions
    • Assess for signs and symptoms of hypoglycemia or hyperglycemia
  • Teach the patient how to recognize signs and symptoms of hypoglycemia and hyperglycemia •Teach the patient to follow recommended diabetic diet and to use the exchange system when planning meals
  • Know that stress, fever, trauma, infection, and surgery may increase insulin requirements or necessitate switching from an oral hypoglycemic to insulin
    • Instruct the patient to carry sugar and drug identification and drug regimen in case of hypoglycemic reaction 7.GLUCAGON - a hyperglycemic drug that raises blood glucose levels, is a hormone normally produced by the alpha cells of the islets of Langerhans in the pancreas; increases blood sugar level in the body ; Glucagon is used for emergency treatment of severe hypoglycemia; It’s also used during radiologic examination of the GI tract to reduce GI motility. MOA: - When adequate stores of glycogen are present, glucagon can raise glucose levels in patients with severe hypoglycemia. Here’s what happens:
    • Initially, glucagon stimulates the formation of adenylate cyclase in the liver cell; Adenylate cyclase then converts adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP); result in an active phosphorylated glucose molecule; In this phosphorylated form, the large glucose molecule can’t pass through the cell membrane; Through glycogenolysis the breakdown of glycogen, the stored form of glucose, the liver removes the phosphate group and allows the glucose to enter the bloodstream, raising blood glucose levels for short-term energy needs. NURSING RESPONSIBILITIES: •Assess the patient’s blood glucose level regularly; Increase monitoring during periods of increased stress •Monitor the patient’s hydration if vomiting occurs.
  • Assess the patient’s and family’s knowledge of drug therapy. •For IM and subcutuse, reconstitute the drug in a 1-unit vial with 1 mL of diluent; reconstitute the drug in a 10-unit vial with 10 mL of diluent.
    • For IV administration, a drip infusion, such as dextrose solution, which is compatible with glucagon, may be used; the drug forms precipitate in chloride solutions. Inject the drug over 2 to 5 minutes.
  • Arouse the lethargic patient as quickly as possible. Give additional carbohydrates orally to prevent a secondary hypoglycemic episode, and then determine the cause of the reaction.
  • Notify the prescriber that the patient’s hypoglycemic episode required glucagon use. •Be prepared to provide emergency intervention if the patient doesn’t respond to glucagon administration; give IV dextrose 50% instead.
    • Notify the prescriber if the patient can’t retain some form of sugar for 1 hour because of nausea or vomiting.